EUROLAB
astm-f2130-endotoxin-testing
Biocompatibility Testing ASTM F1609 Evaluation of Surface ContaminationASTM F1904 Protein Adsorption TestingASTM F1980 Accelerated Aging of Medical DevicesASTM F2027 Cytotoxicity EvaluationASTM F2028 Evaluation of Sterilization ResidualsASTM F2052 Magnetically Induced DisplacementASTM F2080 Durability TestingASTM F2095 Evaluation of Additives in Medical PolymersASTM F2096 Particulate TestingASTM F2100 Medical Mask TestingASTM F2149 Antimicrobial Activity TestingASTM F2180 Sterilization Validation for HydrogelsASTM F2182 RF Induced Heating TestsASTM F2213 Evaluation of Magnetic Resonance CompatibilityASTM F2255 Acute Systemic ToxicityASTM F2273 Cytokine AnalysisASTM F2392 Implant Wear Debris AnalysisASTM F2458 Biofilm Formation TestingASTM F2459 Adhesion of Medical Device CoatingsASTM F2478 Safety Evaluation of PolymersASTM F2503 MR Safety LabelingASTM F2900 Testing of BiopolymersASTM F2941 Shelf Life TestingASTM F640 Extraction of Medical DevicesASTM F748 Evaluation of Medical Device BiocompatibilityASTM F756 Assessment of Hemolytic PropertiesEN ISO 10993-1 Biological Evaluation – Part 1EN ISO 10993-10 Sensitization TestingEN ISO 10993-11 Systemic ToxicityEN ISO 10993-5 Cytotoxicity TestingIEC 60601-1 Safety Requirements for Medical Electrical EquipmentISO 10993-1 Biological Evaluation of Medical DevicesISO 10993-10 Sensitization TestingISO 10993-11 Systemic Toxicity TestingISO 10993-12 Sample Preparation and Reference MaterialsISO 10993-13 Identification and Quantification of Degradation ProductsISO 10993-14 Degradation TestingISO 10993-15 Toxicokinetic StudyISO 10993-16 Toxicokinetic Study ProtocolISO 10993-17 Establishing Allowable LimitsISO 10993-18 Chemical Characterization TechniquesISO 10993-19 Biodegradation TestingISO 10993-2 Animal Welfare RequirementsISO 10993-20 Toxicology Data AnalysisISO 10993-21 Evaluation of Metals and AlloysISO 10993-22 Irradiation of Medical DevicesISO 10993-23 Biological Evaluation of ResidualsISO 10993-24 Toxicological Risk AssessmentISO 10993-25 Genotoxicity in Medical DevicesISO 10993-26 Immunotoxicology TestingISO 10993-27 Implant Material CharacterizationISO 10993-28 Evaluation of Metallic ImplantsISO 10993-29 Extraction ConditionsISO 10993-3 Genotoxicity TestingISO 10993-30 Analytical TechniquesISO 10993-31 Mutagenicity TestingISO 10993-32 Toxicity Tests for Medical PolymersISO 10993-33 Biological Evaluation of Degradation ProductsISO 10993-34 Evaluation of Chemical ResiduesISO 10993-35 Assessment of Extractables and LeachablesISO 10993-36 Nonclinical Safety EvaluationISO 10993-37 Evaluation of Cytokine ReleaseISO 10993-38 Endocrine Disruption TestingISO 10993-39 Evaluation of Material ExtractsISO 10993-4 Hemocompatibility TestingISO 10993-40 Evaluation of HemocompatibilityISO 10993-41 Toxicological Risk Assessment FrameworkISO 10993-42 Assessment of NanomaterialsISO 10993-5 Cytotoxicity TestingISO 10993-6 Local Effects after ImplantationISO 10993-7 Ethylene Oxide ResidualsISO 10993-9 Chemical CharacterizationISO 11135 Ethylene Oxide SterilizationISO 11137 Radiation SterilizationISO 11607 Packaging for Terminally Sterilized DevicesISO 11607-1 Packaging ValidationISO 11607-2 Packaging MaterialsISO 11607-3 Packaging TestingISO 11737-1 Sterilization ValidationISO 11737-2 Microbial Limit TestsISO 11737-3 Bioburden DeterminationISO 13408 Aseptic ProcessingISO 13408-1 Cleanroom TestingISO 13408-2 Aseptic Processing ValidationISO 13485 Quality Management Systems for Medical DevicesISO 13485 Risk Management IntegrationISO 13485-1 Quality System RequirementsISO 14117 Pulse Oximeter PerformanceISO 14155 Clinical Investigation StandardsISO 14155-1 Clinical Trial DesignISO 14155-2 Clinical Trial ConductISO 14160 Biocompatibility for Transfusion EquipmentISO 14161 Sterilization by Ethylene OxideISO 14161 Validation of Sterilization ProcessesISO 14630 Non-active Surgical ImplantsISO 14644 Cleanroom StandardsISO 14708 Active Implantable Medical DevicesISO 14708-3 Active Implantable Device TestingISO 14708-4 Implantable Device SafetyISO 14969 Quality Management for Sterile DevicesISO 14971 Risk Management DocumentationISO 14971 Risk Management for Medical DevicesISO 14971-2 Risk Management ReportingISO 15223 Medical Device SymbolsISO 17025 Testing Laboratory AccreditationISO 18113 Medical Device LabelingISO 18562 Biocompatibility of Breathing Gas PathwaysISO 22442 Medical Device Material TestingISO 25539 Cardiovascular ImplantsISO 25539-2 Coronary StentsISO 7405 Evaluation of Biocompatibility for DentistryISO 80369 Small-Bore ConnectorsUSP <87> Biological Reactivity TestsUSP <88> Tests for Plastic Materials

ASTM F2130 Endotoxin Testing: A Service Provided by Eurolab

Standard-Related Information

ASTM F2130 Endotoxin Testing is a laboratory test that measures the presence of endotoxins in medical devices, pharmaceuticals, and other products. The test is governed by various international and national standards, including ISO 10993-11, ASTM F2100, and EN ISO 10993-11.

The legal and regulatory framework surrounding this testing service is primarily driven by regulations related to product safety and quality. In the United States, for example, the Food and Drug Administration (FDA) requires that medical devices be tested for endotoxins as part of their pre-market approval process. Similarly, in the European Union, the Medical Device Regulation (MDR) requires that medical devices be tested for endotoxins before they can be placed on the market.

The international standards governing ASTM F2130 Endotoxin Testing are developed by organizations such as the International Organization for Standardization (ISO), the American Society for Testing and Materials (ASTM), and the European Committee for Electrotechnical Standardization (CENELEC). These organizations work together to ensure that standards are harmonized across borders and industries.

Standard Requirements and Needs

The need for ASTM F2130 Endotoxin Testing arises from the risk of endotoxins causing adverse reactions in patients or users. Endotoxins, which are components of bacterial cell walls, can be present in medical devices, pharmaceuticals, and other products as a result of manufacturing processes or contamination.

Conducting this test is essential to ensure product safety and reliability. Failure to perform this test can lead to serious consequences, including product recalls, legal liabilities, and damage to brand reputation.

The industries that require ASTM F2130 Endotoxin Testing include medical device manufacturers, pharmaceutical companies, and biotechnology firms. This testing is also relevant to regulatory compliance officers, quality managers, and business owners who need to ensure product safety and reliability.

Test Conditions and Methodology

The test for endotoxins involves the following steps:

1. Sample preparation: The sample is prepared according to the standard procedures outlined in ISO 10993-11 or ASTM F2100.

2. Testing equipment and instruments: The testing is conducted using a validated instrument, such as the Limulus amebocyte lysate (LAL) test kit.

3. Testing environment requirements: The testing must be performed in a controlled environment with specific temperature, humidity, and pressure conditions.

4. Measurement and analysis methods: The endotoxin levels are measured using a validated method, such as the LAL test.

5. Calibration and validation procedures: The instrument is calibrated and validated according to the manufacturers instructions and ISO 15189 guidelines.

Test Reporting and Documentation

The test results are documented in a standard report format that includes the following information:

  • Test method

  • Sample identification

  • Test results (endotoxin levels)

  • Conclusion

    • The reporting standards and formats for this testing service include:

  • EUROLABs standard report template

  • International Organization for Standardization (ISO) 15189 guidelines for laboratory testing

  • European Commissions Medical Device Regulation (MDR) requirements for product safety and quality

    • Why This Test Should Be Performed

    ASTM F2130 Endotoxin Testing is essential to ensure product safety and reliability. The benefits of this test include:

  • Risk assessment and mitigation through testing

  • Quality assurance and compliance benefits

  • Competitive advantages and market positioning

  • Cost savings and efficiency improvements

  • Legal and regulatory compliance benefits

  • Customer confidence and trust building

    • Why Eurolab Should Provide This Service

    Eurolabs expertise and experience in this field make them an ideal provider of ASTM F2130 Endotoxin Testing services. Our state-of-the-art equipment, qualified personnel, and international recognition ensure that our testing meets the highest standards.

    Our quality management systems and procedures guarantee that all testing is performed according to established protocols. Eurolabs customer service and support capabilities ensure that clients receive prompt and efficient results.

    Conclusion

    ASTM F2130 Endotoxin Testing is a critical laboratory test that measures the presence of endotoxins in medical devices, pharmaceuticals, and other products. This comprehensive guide has outlined the standard-related information, testing conditions and methodology, reporting and documentation requirements, and benefits of this testing service.

    Eurolabs expertise, state-of-the-art equipment, qualified personnel, and international recognition make us an ideal provider of ASTM F2130 Endotoxin Testing services.

    Need help or have a question?
    Contact us for prompt assistance and solutions.

    CONTACT US +902127020000

    Latest News

    View all

    Eurolab Successfully Renews ISO 17025 Accreditation

    Read More

    Expanded Cosmetic Safety Testing Portfolio Now Available at Eurolab

    Read More

    Eurolab Launches Technical Training Series for Industry Professionals

    Read More

    JOIN US
    Want to make a difference?

    Careers